Back

Impact of low hemoglobin levels on arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Prediction of atrial fibrillation recurrences: still a challenge Catheter Ablation of Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yasuharu Matsunaga

Osaka Rosai Hospital, Sakai (Japan)

6 More presentations in this session

Presentation thumbnail
How does artificial intelligence-derived electrocardiographic age and sex predict recurrence outcomes after atrial fibrillation catheter ablation?
Doctor H. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The role of pulmonary vein anatomy in predicting atrial arrhythmia recurrence after pulsed-field ablation
Mr M. Mutti (Basel, CH)
Abstract Slides Video
Presentation thumbnail
The impact of atrial fibrillation progression on the epicardial adipose tissue volume: supporting 'AF begets EAT' theory
Doctor K. Shimojo (Ogaki, JP)
Abstract Slides Video
Presentation thumbnail
Common genetic variants associated with characteristics and clinical outcomes of atrial fibrillation: from a large population based registry (FinnGen)
Doctor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Geranylgeranylacetone as prevention for postoperative Atrial Fibrillation (GENIALITY trial)
Doctor K. Silva Ramos (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Prediction of atrial fibrillation recurrences: still a challenge

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Severity of anemia is correlated with the prevalence of left atrial low-voltage areas in patients with atrial fibrillation ablation
thumbnail
Congress Presentation
Effect of the longitudinal change in anemia status on clinical outcomes for patients with nonvalvular atrial fibrillation: analysis from the Hokuriku-Plus AF registry
thumbnail
Congress Presentation
Impact of moderate to severe anemia on clinical outcomes in patients with atrial fibrillation and coronary artery disease requiring percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources